These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 12935436)
41. Transdermal microparticle delivery by a supersonic-Helios gun system. Yi J; Chao W; Mashaki U; Hideshi N; Yasunori M Pharmazie; 2004 Dec; 59(12):934-6. PubMed ID: 15638081 [TBL] [Abstract][Full Text] [Related]
42. [Study on the release of oleanolic acid loaded nanocapsules in vitro]. Huang Y; Li Y; Li XZ; Liu S; Lei P; Xiao J Zhong Yao Cai; 2008 Feb; 31(2):283-5. PubMed ID: 18619279 [TBL] [Abstract][Full Text] [Related]
43. Alkaline hydrolysis as a tool to determine the association form of indomethacin in nanocapsules prepared with poly(eta-caprolactone). Pohlmann AR; Soares LU; Cruz L; da Silveira NP; Guterres SS Curr Drug Deliv; 2004 Apr; 1(2):103-10. PubMed ID: 16305375 [TBL] [Abstract][Full Text] [Related]
44. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres. Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657 [TBL] [Abstract][Full Text] [Related]
45. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
46. Preparation, characterization and permeation studies of a nanovesicular system containing diclofenac for transdermal delivery. Gaur PK; Purohit S; Kumar Y; Mishra S; Bhandari A Pharm Dev Technol; 2014 Feb; 19(1):48-54. PubMed ID: 23281714 [TBL] [Abstract][Full Text] [Related]
47. Pulsed field gradient NMR on polybutylcyanoacrylate nanocapsules. Wohlgemuth M; Mayer C J Colloid Interface Sci; 2003 Apr; 260(2):324-31. PubMed ID: 12686182 [TBL] [Abstract][Full Text] [Related]
48. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Kawadkar J; Pathak A; Kishore R; Chauhan MK Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934 [TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetic evaluation of indomethacin ethyl ester-loaded nanoencapsules. Cattani VB; Pohlmann AR; Dalla Costa T Int J Pharm; 2008 Nov; 363(1-2):214-6. PubMed ID: 18678236 [TBL] [Abstract][Full Text] [Related]
50. Biodegradable polymeric nanocapsules based on poly(DL-lactide) for genistein topical delivery: obtention, characterization and skin permeation studies. Zampieri AL; Ferreira FS; Resende EC; Gaeti MP; Diniz DG; Taveira SF; Lima EM J Biomed Nanotechnol; 2013 Mar; 9(3):527-34. PubMed ID: 23621010 [TBL] [Abstract][Full Text] [Related]
51. Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Evaluation of the topical and systemic anti-inflammatory activity in the rat. Calpena AC; Escribano E; San Martin H; Lauroba J; Obach R; Domenech J Arzneimittelforschung; 1999 Dec; 49(12):1012-7. PubMed ID: 10635447 [TBL] [Abstract][Full Text] [Related]
52. Entrapment efficiency and initial release of phenylbutazone from nanocapsules prepared from different polyesters. Marchais H; Benali S; Irache JM; Tharasse-Bloch C; Lafont O; Orecchioni AM Drug Dev Ind Pharm; 1998 Sep; 24(9):883-8. PubMed ID: 9876542 [TBL] [Abstract][Full Text] [Related]
53. Preparation of chondroitin sulfate nanocapsules for use as carries by the interfacial polymerization method. Xi J; Zhou L; Fei Y Int J Biol Macromol; 2012 Jan; 50(1):157-63. PubMed ID: 22033115 [TBL] [Abstract][Full Text] [Related]
54. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen. Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398 [TBL] [Abstract][Full Text] [Related]
55. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics. Tirunagari M; Jangala VR; Khagga M; Gannu R Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712 [TBL] [Abstract][Full Text] [Related]
56. Pluronic F-127 gels as a vehicle for topical formulations of indomethacin and rheological behaviour of these formulations. Shawesh A; Kallioinen S; Hellén L; Antikainen O; Yliruusi J Pharmazie; 2002 Mar; 57(3):186-90. PubMed ID: 11933848 [TBL] [Abstract][Full Text] [Related]
57. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study. Bernardi A; Frozza RL; Jäger E; Figueiró F; Bavaresco L; Salbego C; Pohlmann AR; Guterres SS; Battastini AM Eur J Pharmacol; 2008 May; 586(1-3):24-34. PubMed ID: 18371953 [TBL] [Abstract][Full Text] [Related]
58. In vitro release kinetic pattern of indomethacin from poly(D,L-lactide) nanocapsules. Ammoury N; Fessi H; Devissaguet JP; Puisieux F; Benita S J Pharm Sci; 1990 Sep; 79(9):763-7. PubMed ID: 2273454 [TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics on a microscale: visualizing Cy5-labeled oligonucleotide release from poly(n-butylcyanoacrylate) nanocapsules in cells. Tomcin S; Baier G; Landfester K; Mailänder V Int J Nanomedicine; 2014; 9():5471-89. PubMed ID: 25473285 [TBL] [Abstract][Full Text] [Related]
60. Design and Optimization of Cationic Nanocapsules for Topical Delivery of Tretinoin: Application of the Box-Behnken Design, Ebrahimi S; Mahjub R; Haddadi R; Vafaei SY Biomed Res Int; 2021; 2021():4603545. PubMed ID: 34934769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]